Evaluation of Mycobacterium tuberculosis cross-resistance to isoniazid, rifampicin and levofloxacin with their respective structural analogs

Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis

Amalio Telenti, Paul Imboden, Federica Marchesi et al. · The Lancet · 1993 · 1.3K citations

Life Sciences, Infectious Diseases, Microbiology +14

Modification of the NADH of the Isoniazid Target (InhA) from <i>Mycobacterium tuberculosis</i>

Denise A. Rozwarski, Gregory A. Grant, D. H. R. BARTON et al. · Science · 1998 · 680 citations

Medicine, Biochemistry, Pharmacology +16

Population Genetics Study of Isoniazid Resistance Mutations and Evolution of Multidrug-Resistant <i>Mycobacterium tuberculosis</i>

Manzour Hernando Hazbón, Michael Brimacombe, Magali Cavatore et al. · Antimicrobial Agents and Chemotherapy · 2006 · 386 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

<i>ethA</i> , <i>inhA</i> , and <i>katG</i> Loci of Ethionamide-Resistant Clinical <i>Mycobacterium tuberculosis</i> Isolates

Glenn P. Morlock, Beverly Metchock, David Sikes et al. · Antimicrobial Agents and Chemotherapy · 2003 · 288 citations · Full text

Life Sciences, Microbiology, Molecular Biology +15

Contribution of <i>rpoB</i> Mutations to Development of Rifamycin Cross-Resistance in <i>Mycobacterium tuberculosis</i>

Diana L. Williams, Laynette Spring, L A Collins et al. · Antimicrobial Agents and Chemotherapy · 1998 · 238 citations · Full text

Life Sciences, Genetics, Microbiology +17